Article (Scientific journals)
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Devy, L.; Blacher, Silvia; Grignet, Christine et al.
2002In FASEB Journal, 16 (2), p. 147-54
Peer Reviewed verified by ORBi
 

Files


Full Text
Devy L Faseb 2002.pdf
Publisher postprint (380.82 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
angiogenesis; cell migration; proteolysis; serine protease; PAI-1
Abstract :
[en] Plasminogen activator inhibitor 1 (PAI-1) is believed to control proteolytic activity and cell migration during angiogenesis. We previously demonstrated in vivo that this inhibitor is necessary for optimal tumor invasion and vascularization. We also showed that PAI-1 angiogenic activity is associated with its control of plasminogen activation but not with the regulation of cell-matrix interaction. To dissect the role of the various components of the plasminogen activation system during angiogenesis, we have adapted the aortic ring assay to use vessels from gene-inactivated mice. The single deficiency of tPA, uPA, or uPAR, as well as combined deficiencies of uPA and tPA, did not dramatically affect microvessel formation. Deficiency of plasminogen delayed microvessel outgrowth. Lack of PAI-1 completely abolished angiogenesis, demonstrating its importance in the control of plasmin-mediated proteolysis. Microvessel outgrowth from PAI-1(-/-) aortic rings could be restored by adding exogenous PAI-1 (wild-type serum or purified recombinant PAI-1). Addition of recombinant PAI-1 led to a bell-shaped angiogenic response clearly showing that PAI-1 is proangiogenic at physiological concentrations and antiangiogenic at higher levels. Using specific PAI-1 mutants, we could demonstrate that PAI-1 promotes angiogenesis at physiological (nanomolar) concentrations through its antiproteolytic activity rather than by interacting with vitronectin.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Devy, L.
Blacher, Silvia ;  Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Grignet, Christine ;  Université de Liège - ULiège > Services administratifs généraux > Protection et hygiène du travail (SUPHT)
Bajou, Khalid ;  Université de Liège - ULiège > Département des sciences de la vie > Biologie et génétique moléculaire
Masson, Véronique ;  Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Gerard, R. D.
Gils, A.
Carmeliet, G.
Carmeliet, P.
Declerck, P. J.
Noël, Agnès ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Foidart, Jean-Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Language :
English
Title :
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Publication date :
February 2002
Journal title :
FASEB Journal
ISSN :
0892-6638
eISSN :
1530-6860
Publisher :
Federation of American Society for Experimental Biology, Bethesda, United States - Maryland
Volume :
16
Issue :
2
Pages :
147-54
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 March 2009

Statistics


Number of views
70 (3 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
254
Scopus citations®
without self-citations
214
OpenCitations
 
192

Bibliography


Similar publications



Contact ORBi